Alkeon Capital Management LLC Tg Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

$48.3 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $17.7 Million - $40 Million	-1,142,048 Reduced 42.46%	1,547,875 $38.4 Million
Q1 2023 May 12, 2023	SELL	$10.23 - $19.34 $3.63 Million - $6.86 Million	-354,494 Reduced 11.64%	2,689,923 $40.5 Million
Q4 2022 Feb 13, 2023	BUY	$5.01 - $11.83 $7.02 Million - $16.6 Million	1,401,742 Added 85.33%	3,044,417 $36 Million
Q3 2022 Nov 10, 2022	SELL	$4.57 - $8.4 $568,759 - $1.05 Million	-124,455 Reduced 7.04%	1,642,675 $9.73 Million
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $115,491 - $329,180	-30,880 Reduced 1.72%	1,767,130 $7.51 Million
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $548,972 - $1.44 Million	-70,291 Reduced 3.76%	1,798,010 $17.1 Million
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $33.4 Million - $78.1 Million	-2,200,000 Reduced 54.08%	1,868,301 $35.5 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $309,145 - $574,147	-14,194 Reduced 0.35%	4,068,301 $135 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $266,370 - $401,276	-8,196 Reduced 0.2%	4,082,495 $158 Million
Q1 2021 May 17, 2021	BUY	$41.61 - $54.3 $521,498 - $680,541	12,533 Added 0.31%	4,090,691 $197 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $32.9 Million - $71.5 Million	1,303,158 Added 46.96%	4,078,158 $212 Million
Q3 2020 Nov 16, 2020	BUY	$18.49 - $27.24 $9.43 Million - $13.9 Million	510,000 Added 22.52%	2,775,000 $74.3 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $6.23 Million - $15.3 Million	700,000 Added 44.73%	2,265,000 $44.1 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $4.03 Million - $9.03 Million	565,000 Added 56.5%	1,565,000 $15.4 Million
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $5.1 Million - $11.2 Million	1,000,000 New	1,000,000 $11.1 Million

Others Institutions Holding TGTX

# of Institutions

373

Shares Held

85.5M

Call Options Held

3.78M

Put Options Held

Vanguard Group Inc Valley Forge, PA

15.6M
Shares

$622 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$454 Million
0.0% of portfolio
State Street Corp Boston, MA

9.2M
Shares

$367 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

3.19M
Shares

$127 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

2.79M
Shares

$111 Million
0.09% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.79B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account